ovarian cancer

In this illustration, ERX-41 (green stick figure) is bound to the lysosomal acid lipase A protein, a process that leads to cancer-cell death.

A new molecule kills a broad spectrum of hard-to-treat cancers including triple-negative breast cancer

Screening entire populations for breast and ovarian cancer gene mutations could prevent millions of cancer cases

Using the body’s own defenses to track down and kill escaping cancer cells during surgeries

Novel imaging system could help boost survival rates for ovarian cancer

Synthetic biomarkers could be used to diagnose ovarian cancer months earlier than now possible

Stanford Researchers Create “Evolved” Protein that May Stop Cancer from Spreading

The new MIT nanoparticles consist of polymer chains (blue) and three different drug molecules — doxorubicin is red, the small green particles are camptothecin, and the larger green core contains cisplatin. Image courtesy of Jeremiah Johnson

Targeting cancer with a triple threat

Gagomers (labeled in color) accumulating on ovarian cancer cells

Researchers Devise a Fast and Effective Mechanism to Combat One of the Most Aggressive Cancers

New Screening Strategy May Catch Ovarian Cancer at Early Stages

Supreme Court Rejects Patents on 2 Naturally Occurring Genes

B.C. scientists discover breakthrough cancer mutation

Potential breakthrough in treating late-stage ovarian cancer

Magnetic nanotags detect cancer much earlier than current methods

Electronic Nose Detects Cancer

Judge Invalidates Human Gene Patent